Clinical Trials
11 trialsNCT06751524 2026-05-15
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus Inc.
Available
NCT06810141 2026-05-14
ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer
ImmunityBio, Inc.
Available
NCT06443944 2026-04-14
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
CG Oncology, Inc.
Available
NCT04091295 2026-03-04
BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast
Aveni Foundation
Available
NCT06836648 2026-02-25
Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Available
NCT04566393 2026-01-28
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
xCures
Available
NCT05974410 2025-10-02
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
AVM Biotechnology Inc
Available
NCT06090331 2025-07-08
89Zr-DFO-girentuximab Expanded Access Program (EAP)
Telix Pharmaceuticals (Innovations) Pty Limited
Available
NCT05650476 2025-06-12
Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)
Pfizer
Available
NCT05494411 2025-02-28
Named Patient Program for Mitomycin for Pyelocalyceal Solution
UroGen Pharma Ltd.
Available
NCT04337099 2021-05-05
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
Matrix Biomed, Inc.
Available